Connect with us

Australia

MMJ Group investment gains R&D licence in Canada and starts sales in Argentina

MMJ Group Holdings Ltd (ASX:MMJ) investment Harvest One Cannabis Incs (CVE: HVT) subsidiary Satipharm Ltd has received an R&D licence for its products in Canada and has started sales into Argentina.

Harvest Ones licensed producer United Greeneries Ltd has received permission from Health Canada to import Satipharms CBD Gelpell® capsules into Canada for research and development purposes.

This allows Harvest One to begin compliance testing and analysis for the Canadian market in anticipation of full-scale production in Canada in 2020.

Initial shipment received
Satipharms CBD Gelpell® capsules are also now available in Argentina for medical purposes and the initial shipment has been received by the first patient.

In March 2017, the Argentine Congress approved a new medical cannabis law which authorises the import of cannabis products for sufferers of refractory epilepsy for patients with a doctors prescription.

Satipharm has signed an agreement with FederalMed to manage the importatio..

MMJ Group Holdings Ltd (ASX:MMJ) investment Harvest One Cannabis Incs (CVE: HVT) subsidiary Satipharm Ltd has received an R&D licence for its products in Canada and has started sales into Argentina.

Harvest Ones licensed producer United Greeneries Ltd has received permission from Health Canada to import Satipharms CBD Gelpell® capsules into Canada for research and development purposes.

This allows Harvest One to begin compliance testing and analysis for the Canadian market in anticipation of full-scale production in Canada in 2020.

Initial shipment received

Satipharms CBD Gelpell® capsules are also now available in Argentina for medical purposes and the initial shipment has been received by the first patient.

In March 2017, the Argentine Congress approved a new medical cannabis law which authorises the import of cannabis products for sufferers of refractory epilepsy for patients with a doctors prescription.

Satipharm has signed an agreement with FederalMed to manage the importation and distribution of CBD Gelpell® capsules to patients.

“Key part” of strategy

Harvest Ones CEO Grant Froese said, “At Harvest One, we view the Satipharm CBD Gelpell® capsule as a key part of our health, wellness, and self-care strategy and are very excited to be taking the next step in bringing them to the Canadian market.

“With this import permit, Harvest One can continue the necessary preparations to bring this unique, effective product to Canada.

“We are equally excited to have our first shipment of Satipharms CBD Gelpell® capsules to Argentina, which marks Harvest Ones first entry into South America.

“This adds to our existing distribution which includes 2,000 stores in the UK and Ireland, on-line sales across the EU and prescription sales in Australia.”

Unique CBD capsules

Satipharm produces a CBD capsule using the proprietary Gelpell® process and these capsules take a different approach to other cannabinoid pills on the market in Canada and internationally.

Gelpell® capsules contain full-spectrum hemp extract CBD in seamless gelatine beads.

These microbeads, contained in a hard gastro-resistant capsule, release the CBD in the small intestine and maximise the delivery of CBD to the body.

Manufactured in Switzerland, and GMP certified, every Gelpell® capsule delivers a consistent dose of cannabinoids.

NTA at October 31

MMJ Group, which has a diversified portfolio of cannabis sector investments, has released its net tangible assets (NTA) per share as at October 31, 2019, pursuant to ASX Listing Rule 4.12.

NTA per share as at that date was A30.52 cents pre-tax and A28.53 cents post-tax.

The year to date performance of MMJs NTA.

The company seeks investments across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment, and retail.

One of MMJs key aims is for the share price to trade at a premium to Net Asset Value given the potential returns from portfolio companies which include investments in private cannabis and hemp businesses which are on a short path to public listing or sale of the business.

MMJs investment portfolio as at 31 October 2019.

Seeking NASDAQ listing

Another MMJ Group investment Read More – Source

Continue Reading

Australia

S&P/ASX 200 loses steam after China approves controversial Hong Kong security law

S&P/ASX 200 (INDEXASX:XJO) finished 76 points or 1.32% higher today at 5851 – touching a new 11-week high in the process.

The market broke through the 5900 barrier for the first time since March 11 but dropped during afternoon trade as oil prices fell and geopolitical tensions flared.

The index had risen by as much as 2.5% on a strong lead from Wall Street but sagged as China's legislature approved a proposal to impose the controversial National Security Law in Hong Kong.

Top gainers[hhmc]
Top gainers on the ASX today include Bellevue Gold Ltd (ASX:BGL) (+11.11%), Vrx Silica Ltd (ASX:VRX) (+9.37%), MacArthur Minerals Ltd (ASX:MIO) (+10.53%), Musgrave Minerals Ltd (ASX:MGV) (7.41%), Northern Minerals Ltd (ASX:NTU) (+9.09%), Predictive Discovery Ltd (ASX:PDI) (+10.23%) and Twenty Seven Co Ltd (ASX:TSC) (+16.67%).

Proactive news headlines:
Fe Limited step closer to completing $7 million iron ore royalty sale with buyer gaining FIRB approval[hhmc]
Fe Limited (ASX:FEL) is a step cl..

S&P/ASX 200 (INDEXASX:XJO) finished 76 points or 1.32% higher today at 5851 – touching a new 11-week high in the process.

The market broke through the 5900 barrier for the first time since March 11 but dropped during afternoon trade as oil prices fell and geopolitical tensions flared.

The index had risen by as much as 2.5% on a strong lead from Wall Street but sagged as China's legislature approved a proposal to impose the controversial National Security Law in Hong Kong.

Top gainers


Top gainers on the ASX today include Bellevue Gold Ltd (ASX:BGL) (+11.11%), Vrx Silica Ltd (ASX:VRX) (+9.37%), MacArthur Minerals Ltd (ASX:MIO) (+10.53%), Musgrave Minerals Ltd (ASX:MGV) (7.41%), Northern Minerals Ltd (ASX:NTU) (+9.09%), Predictive Discovery Ltd (ASX:PDI) (+10.23%) and Twenty Seven Co Ltd (ASX:TSC) (+16.67%).

Proactive news headlines:

Fe Limited step closer to completing $7 million iron ore royalty sale with buyer gaining FIRB approval


Fe Limited (ASX:FEL) is a step closer to receiving $7 million for the sale of its Evanston iron ore royalty interest after buyer Trident Resources PLC (LSE:TRR) received approval from the Foreign Investment Review Board of Australia (FIRB). The only remaining condition to complete the transaction is Trident listing on AIM, which is targeted to occur next week.

Lake Resources looks incredibly undervalued with significant advantages: Orior Capital


Lake Resources NL (ASX:LKE) (OTC:LLKKF) is incredibly undervalued as per a new research report by Orior Capitals Simon Francis, a former top-rated metals and mining analyst in Asia with Macquarie, Credit Suisse and HSBC. This research highlights the potential value of Lakes Kachi Lithium Brine Project in Argentina following the recently released pre-feasibility study (PFS) concerning its sustainable and scalable direct extraction process.

Gold Road on track to produce 250,000-285,000 ounces at Gruyere this year


Gold Road Resources Ltd (ASX:GOR) became one of Australias newest gold producers in June 2019, achieving its first gold pour from the Gruyere Gold Mine in WA along with JV partner Gold Fields Limited (JSE:GFI). Gruyere 2020 gold production for the calendar year is forecast between 250,000 – 285,000 ounces (125,000 – 142,500 ounces attributable to Gold Road).

Imugene research published in prestigious journal titled Frontiers in Immunology


Imugene Ltds (ASX:IMU) preclinical research to improve mimotope vaccines targeting checkpoint inhibitors has been accepted and published in the prestigious journal Frontiers in Immunology.

Ground-breaking research from Vienna identified mimotope peptides that when incorporated into Imugenes proprietary immunotherapeutic vaccine delivery platform generate antibodies that bind specifically to immune cells expressing the PD1 biomarker.

Cassini Resources at 12-month high after intersecting nickel-copper-sulphide in first Yarrawindah Brook holes


Cassini Resources Ltd (ASX:CZI) has intersected nickel-copper sulphide in the first two drill holes at Yarrawindah Brook Project 100 kilometres northeast of Perth, Western Australia. The first two drill holes of a diamond drilling program at Ovis and Ovis down-plunge extension prospects have been completed and a third hole, testing a new elecRead More – Source

Continue Reading

Australia

Fe Limited step closer to completing $7 million iron ore royalty sale with buyer gaining FIRB approval

Fe Limited (ASX:FEL) is a step closer to receiving $7 million for the sale of its Evanston iron ore royalty interest after buyer Trident Resources PLC (LSE:TRR) received approval from the Foreign Investment Review Board of Australia (FIRB).

The only remaining condition to complete the transaction is Trident listing on AIM, which is targeted to occur next week.

Sale of the royalty, which covers a portion of the Koolyanobbing Iron Ore Mine in Western Australia was overwhelmingly approved by FEL shareholders at an extraordinary general meeting.

Financial certainty[hhmc]
This sale provides certainty for FELs financing position as the royalty stream is variable and depends on a range of factors such as the iron ore price, currency and production rates over which FEL has no control.

The Evanston royalty has seen FEL receive $1.829 million in the last 12 months from the sale of 1.228 million tonnes following the recommissioning of the mine in December 2018.

A sale and purchase agreement ..

Fe Limited (ASX:FEL) is a step closer to receiving $7 million for the sale of its Evanston iron ore royalty interest after buyer Trident Resources PLC (LSE:TRR) received approval from the Foreign Investment Review Board of Australia (FIRB).

The only remaining condition to complete the transaction is Trident listing on AIM, which is targeted to occur next week.

Sale of the royalty, which covers a portion of the Koolyanobbing Iron Ore Mine in Western Australia was overwhelmingly approved by FEL shareholders at an extraordinary general meeting.

Financial certainty


This sale provides certainty for FELs financing position as the royalty stream is variable and depends on a range of factors such as the iron ore price, currency and production rates over which FEL has no control.

The Evanston royalty has seen FEL receive $1.829 million in the last 12 months from the sale of 1.228 million tonnes following the recommissioning of the mine in December 2018.

A sale and purchase agreement with TRR Services Australia Pty Ltd, a subsidiary of Trident Resources, provides for cash consideration to be paid in two instalments.

The first $4 million is payable upon completion of the transaction and the remainder is payable one day after the first anniversary of completion.

Funds to support exploration


Funds from the sale will provide FEL with the necessary funding to support ongoing exploration programs.

This includes follow-up works to the drilling comRead More – Source

Continue Reading

Australia

Lake Resources looks incredibly undervalued with significant advantages: Orior Capital

Lake Resources NL (ASX:LKE) (OTC:LLKKF) is incredibly undervalued as per a new research report by Orior Capitals Simon Francis, a former top-rated metals and mining analyst in Asia with Macquarie, Credit Suisse and HSBC.

This research highlights the potential value of Lakes Kachi Lithium Brine Project in Argentina following the recently released pre-feasibility study (PFS) concerning its sustainable and scalable direct extraction process.

The Hong Kong-based analyst highlighted Kachis significant and sustainable competitive advantages including its ability to produce a 99.9% lithium carbonate battery-grade product with low impurities, based on a sustainable process, as sought by electric vehicle (EV) makers.

Francis' research references the production of the samples from the pilot plant modules as being a critical value catalyst for Lake.

The report also highlights the growing global demand for lithium as EV penetration increases, yet challenges to supply are expected to resul..

Lake Resources NL (ASX:LKE) (OTC:LLKKF) is incredibly undervalued as per a new research report by Orior Capitals Simon Francis, a former top-rated metals and mining analyst in Asia with Macquarie, Credit Suisse and HSBC.

This research highlights the potential value of Lakes Kachi Lithium Brine Project in Argentina following the recently released pre-feasibility study (PFS) concerning its sustainable and scalable direct extraction process.

The Hong Kong-based analyst highlighted Kachis significant and sustainable competitive advantages including its ability to produce a 99.9% lithium carbonate battery-grade product with low impurities, based on a sustainable process, as sought by electric vehicle (EV) makers.

Francis' research references the production of the samples from the pilot plant modules as being a critical value catalyst for Lake.

The report also highlights the growing global demand for lithium as EV penetration increases, yet challenges to supply are expected to result in growing supply deficits by the mid-2020s, particularly for battery-grade products.

Valuation of 29 cents per share


Noting that Lake looks incredibly undervalued Francis said: "Despite robust financial metrics, the advantages of direct extraction and the excellent long-term outlook for lithium, Lake Resources is trading at less than 2% of NPV.

“Canadian company Standard Lithium, which is also developing a direct extraction project is trading at ~20% of attributable NPV.

“In February 2020, Orocobre paid an estimated 16% of NPV to acquire Advantage Lithium.

“Valuing Kachi at 15% of NPV and Lakes other projects at say, A$25m, suggests a valuation of A$0.29 per share. This is ~9x the current share price."

Shares today have been as much as 14% higher to 4 cents and are up from 2.5 cents at close on March 24.

Pilot plant progress


Following Lakes recent release of the Kachi PFS, the company has intensified discussions with downstream participants and financers.

Lake is also processing lithium brine samples from Kachi at its technology partner, Lilac Solutions direct extraction pilot plant module in Oakland, California.

Lilac hRead More – Source

Continue Reading

Trending